Skip to content
10-Q

Quarterly Report

Dicerna Pharmaceuticals Inc

0001399529-21-000142

← back to feed
Filed
Aug 9, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Aug 2, 2021 77.73M sh
Shares Diluted Q2 2021 · Jun 30, 2021 77.03M sh
Shares Diluted Q2 2021 · Jun 30, 2021 76.64M sh
Shares Diluted Q2 2021 · Jun 30, 2020 74M sh
Shares Diluted Q2 2021 · Jun 30, 2020 73.46M sh
Capex Q2 2021 · Jun 30, 2021 $8.22M
Capex Q2 2021 · Jun 30, 2020 $3.36M
Operating Cash Flow Q2 2021 · Jun 30, 2021 $132.14M
Operating Cash Flow Q2 2021 · Jun 30, 2020 $279.42M
Cash And Equivalents Q2 2021 · Jun 30, 2021 $221.21M
Cash And Equivalents Q2 2021 · Dec 31, 2020 $126.02M
Cash And Equivalents Q2 2021 · Jun 30, 2020 $197.8M
Stockholders Equity Q2 2021 · Jun 30, 2021 $111.07M
Stockholders Equity Q2 2021 · Mar 31, 2021 $126.4M
Stockholders Equity Q2 2021 · Dec 31, 2020 $137.75M
Stockholders Equity Q2 2021 · Jun 30, 2020 $162.17M
Stockholders Equity Q2 2021 · Mar 31, 2020 $177.91M
Stockholders Equity Q2 2021 · Dec 31, 2019 $152.2M
Current Liabilities Q2 2021 · Jun 30, 2021 $207.65M
Current Liabilities Q2 2021 · Dec 31, 2020 $177.94M
Total Liabilities Q2 2021 · Jun 30, 2021 $727.42M
Total Liabilities Q2 2021 · Dec 31, 2020 $570.09M
Current Assets Q2 2021 · Jun 30, 2021 $616.49M
Current Assets Q2 2021 · Dec 31, 2020 $618.7M
Total Assets Q2 2021 · Jun 30, 2021 $838.49M
Total Assets Q2 2021 · Dec 31, 2020 $707.85M
Eps Diluted Q2 2021 · Jun 30, 2021 −$0.53
Eps Diluted Q2 2021 · Jun 30, 2021 −$0.92
Eps Diluted Q2 2021 · Jun 30, 2020 −$0.43
Eps Diluted Q2 2021 · Jun 30, 2020 −$0.74
Eps Basic Q2 2021 · Jun 30, 2021 −$0.53
Eps Basic Q2 2021 · Jun 30, 2021 −$0.92
Eps Basic Q2 2021 · Jun 30, 2020 −$0.43
Eps Basic Q2 2021 · Jun 30, 2020 −$0.74
Sga Expense Q2 2021 · Jun 30, 2021 $25.46M
Sga Expense Q2 2021 · Jun 30, 2021 $46.13M
Sga Expense Q2 2021 · Jun 30, 2020 $20.57M
Sga Expense Q2 2021 · Jun 30, 2020 $36.59M
Rd Expense Q2 2021 · Jun 30, 2021 $56.12M
Rd Expense Q2 2021 · Jun 30, 2021 $112.16M
Rd Expense Q2 2021 · Jun 30, 2020 $53.38M
Rd Expense Q2 2021 · Jun 30, 2020 $96.55M
Net Income Q2 2021 · Jun 30, 2021 −$40.82M
Net Income Q2 2021 · Jun 30, 2021 −$70.78M
Net Income Q2 2021 · Mar 31, 2021 −$29.97M
Net Income Q2 2021 · Jun 30, 2020 −$31.82M
Net Income Q2 2021 · Jun 30, 2020 −$54.31M
Net Income Q2 2021 · Mar 31, 2020 −$22.49M
Operating Income Q2 2021 · Jun 30, 2021 −$40.24M
Operating Income Q2 2021 · Jun 30, 2021 −$69.35M
Operating Income Q2 2021 · Jun 30, 2020 −$33.49M
Operating Income Q2 2021 · Jun 30, 2020 −$58.66M
Revenue Q2 2021 · Jun 30, 2021 $41.34M
Revenue Q2 2021 · Jun 30, 2021 $88.94M
Revenue Q2 2021 · Jun 30, 2020 $40.45M
Revenue Q2 2021 · Jun 30, 2020 $74.48M